Capricor Therapeutics (CAPR) Gains (Losses) on Sale of Assets & Investments (2013 - 2026)
Capricor Therapeutics (CAPR) recorded Non Operating Investment Income of -$81,143 in Q1 2026, compared with -$150,673 a year earlier.
Powered by 
Analysis
Capricor Therapeutics (CAPR) Gains (Losses) on Sale of Assets & Investments (2013 - 2026) Analysis & Trends
On a TTM basis, Capricor Therapeutics' Non Operating Investment Income came in at -$87,989 as of Mar 31, 2026; for FY2025, it was -$157,519.
- Across earlier years, Non Operating Investment Income came in at -$112,805 in FY2024, -$6,041 in FY2023, -$34,266 in FY2022 and -$7,905 in FY2021.
- Quarterly Non Operating Investment Income has ranged from -$150,673 in Q1 2025 to -$653.00 in Q4 2023 over the past five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Capricor Therapeutics | 515.69 Mn | -516.56 Mn | - | 9,648.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 9,648.00 |
| Jun 30, 2026 | 90,186.00 |
| Mar 31, 2026 | -81,143.00 |
| Sep 30, 2025 | -6,846.00 |
| Jun 30, 2025 | -424,353.00 |
| Mar 31, 2025 | -150,673.00 |
| Dec 31, 2024 | 26,787.00 |
| Sep 30, 2024 | -58,766.00 |
| Jun 30, 2024 | -152,714.00 |
| Mar 31, 2024 | 71,888.00 |
| Dec 31, 2023 | -653.00 |
| Sep 30, 2023 | -5,388.00 |
| Jun 30, 2023 | 84,707.00 |
| Mar 31, 2023 | -10,258.00 |
| Dec 31, 2022 | -34,266.00 |
| Sep 30, 2022 | 99,637.00 |
| Jun 30, 2022 | 22,830.00 |
| Dec 31, 2021 | -7,905.00 |
| Mar 31, 2020 | 757.00 |
| Jun 30, 2019 | -2,720.00 |
API Access
Capricor Therapeutics Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CAPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "CAPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CAPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();